Latest ACUTA CAPITAL PARTNERS, LLC Stock Portfolio
ACUTA CAPITAL PARTNERS, LLC Performance:
2025 Q3: 39.86%YTD: 33.86%2024: 23.91%
Performance for 2025 Q3 is 39.86%, and YTD is 33.86%, and 2024 is 23.91%.
About ACUTA CAPITAL PARTNERS, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, ACUTA CAPITAL PARTNERS, LLC reported an equity portfolio of $96.8 Millions as of 30 Sep, 2025.
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are OCUL, CDTX, . The fund has invested 14.1% of it's portfolio in OCULAR THERAPEUTIX INC and 14% of portfolio in CIDARA THERAPEUTICS INC.
The fund managers got completely rid off SOLENO THERAPEUTICS INC (SLNO), TREVI THERAPEUTICS INC (TRVI) and HELIX ACQUISITION CORP II stocks. They significantly reduced their stock positions in REVOLUTION MEDICINES INC (RVMD), ASCENDIS PHA-ADR and PRAXIS PRECISION MEDICINES I (PRAX). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in AMYLYX PHARMACEUTICALS INC (AMLX), COMPASS THERAPEUTICS INC (CMPX) and KRYSTAL BIOTECH INC (KRYS). The fund showed a lot of confidence in some stocks as they added substantially to BRIGHT MINDS BIOSCIENCES INC, OCULAR THERAPEUTIX INC (OCUL) and TERNS PHARMACEUTICALS INC (TERN).
The top stock holdings of ACUTA CAPITAL PARTNERS, LLC are OCUL, CDTX, . The fund has invested 14.1% of it's portfolio in OCULAR THERAPEUTIX INC and 14% of portfolio in CIDARA THERAPEUTICS INC.
The fund managers got completely rid off SOLENO THERAPEUTICS INC (SLNO), TREVI THERAPEUTICS INC (TRVI) and HELIX ACQUISITION CORP II stocks. They significantly reduced their stock positions in REVOLUTION MEDICINES INC (RVMD), ASCENDIS PHA-ADR and PRAXIS PRECISION MEDICINES I (PRAX). ACUTA CAPITAL PARTNERS, LLC opened new stock positions in AMYLYX PHARMACEUTICALS INC (AMLX), COMPASS THERAPEUTICS INC (CMPX) and KRYSTAL BIOTECH INC (KRYS). The fund showed a lot of confidence in some stocks as they added substantially to BRIGHT MINDS BIOSCIENCES INC, OCULAR THERAPEUTIX INC (OCUL) and TERNS PHARMACEUTICALS INC (TERN).
ACUTA CAPITAL PARTNERS, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that ACUTA CAPITAL PARTNERS, LLC made a return of 39.86% in the last quarter. In trailing 12 months, it's portfolio return was 27.8%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| amylyx pharmaceuticals inc | 4,528,980 |
| compass therapeutics inc | 2,940,320 |
| krystal biotech inc | 1,866,450 |
| cogent biosciences inc | 1,477,740 |
| dianthus therapeutics inc | 983,750 |
| united therapeutics corp | 962,506 |
| inhibrx biosciences inc | 551,577 |
| lb pharmaceuticals inc | 473,700 |
New stocks bought by ACUTA CAPITAL PARTNERS, LLC
Additions
| Ticker | % Inc. |
|---|---|
| bright minds biosciences inc | 75.09 |
| ocular therapeutix inc | 14.81 |
| terns pharmaceuticals inc | 8.39 |
| surrozen inc | 4.95 |
| insmed inc | 4.11 |
Additions to existing portfolio by ACUTA CAPITAL PARTNERS, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| revolution medicines inc | -84.9 |
| ascendis pha-adr | -56.63 |
| praxis precision medicines i | -32.85 |
| cidara therapeutics inc | -21.18 |
| taysha gene therapies inc | -6.35 |
| tourmaline bio inc | -5.37 |
| argen se - adr | -4.82 |
| unicycive therapeutics inc | -4.63 |
ACUTA CAPITAL PARTNERS, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| trevi therapeutics inc | -2,700,730 |
| helix acquisition corp ii | -1,988,670 |
| liquidia corporation | -945,415 |
| soleno therapeutics inc | -5,314,670 |
| artiva biotherapeutics inc | -68,639 |
| ultragenyx pharmaceutical inc | -865,877 |
| rapport therapeutics inc | -227,400 |
| akero therapeutics inc | -1,055,030 |
ACUTA CAPITAL PARTNERS, LLC got rid off the above stocks
Sector Distribution
ACUTA CAPITAL PARTNERS, LLC has about 69.2% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 69.2 |
| Others | 30.8 |
Market Cap. Distribution
ACUTA CAPITAL PARTNERS, LLC has about 6.7% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- SMALL-CAP
- MICRO-CAP
- NANO-CAP
- LARGE-CAP
- MID-CAP
| Category | % |
|---|---|
| UNALLOCATED | 30.8 |
| SMALL-CAP | 24.3 |
| MICRO-CAP | 23 |
| NANO-CAP | 9.3 |
| LARGE-CAP | 6.7 |
| MID-CAP | 5.8 |
Stocks belong to which Index?
About 43.4% of the stocks held by ACUTA CAPITAL PARTNERS, LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 56.6 |
| RUSSELL 2000 | 43.4 |
ACUTA CAPITAL PARTNERS, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC has 28 stocks in it's portfolio. About 76% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for ACUTA CAPITAL PARTNERS, LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AADI | whitehawk therapeutics inc | 6.70 | 3,410,400 | 6,479,760 | unchanged | 0.00 | ||
| AKRO | akero therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMLX | amylyx pharmaceuticals inc | 4.68 | 333,258 | 4,528,980 | new | |||
| CDTX | cidara therapeutics inc | 14.01 | 141,529 | 13,552,800 | reduced | -21.18 | ||
| CMPX | compass therapeutics inc | 3.04 | 840,090 | 2,940,320 | new | |||
| COGT | cogent biosciences inc | 1.53 | 102,907 | 1,477,740 | new | |||
| FULC | fulcrum therapeutics inc | 0.54 | 57,141 | 525,697 | reduced | -4.21 | ||
| INSM | insmed inc | 5.74 | 38,592 | 5,557,630 | added | 4.11 | ||
| JAZZ | jazz pharmaceuticals plc | 3.42 | 25,114 | 3,310,020 | reduced | -4.45 | ||
| KRYS | krystal biotech inc | 1.93 | 10,573 | 1,866,450 | new | |||
| LQDA | liquidia corporation | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| NUVB | nuvation bio inc -cw27 | 0.02 | 90,832 | 18,357 | unchanged | 0.00 | ||
| OCUL | ocular therapeutix inc | 14.08 | 1,165,210 | 13,621,300 | added | 14.81 | ||
| PRAX | praxis precision medicines i | 2.72 | 49,751 | 2,636,800 | reduced | -32.85 | ||
| RARE | ultragenyx pharmaceutical inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RVMD | revolution medicines inc | 0.41 | 8,411 | 392,794 | reduced | -84.9 | ||
| SLNO | soleno therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SRZN | surrozen inc | 2.38 | 178,415 | 2,298,880 | added | 4.95 | ||
| TERN | terns pharmaceuticals inc | 3.90 | 502,797 | 3,776,000 | added | 8.39 | ||
| TRVI | trevi therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||